All Releases
 |
PPD Appoints Neil McCullough, Ph.D., Vice President of Quality Management Systems
Aug 25, 2010
|
9.1 KB |
|
| |
WILMINGTON, N.C. (August 25, 2010) - PPD, Inc. (Nasdaq: PPDI) today announced it has named Neil McCullough, Ph.D., as vice president of quality management systems. In this role, Dr. McCullough will provide strategic direction for quality management across all lines of business and ensure full compliance with global regulations guiding the...
|
|
PPD Declares Third Quarter Dividend
Aug 17, 2010
|
8.7 KB |
|
| |
WILMINGTON, N.C. (August 17, 2010) -- PPD, Inc. (Nasdaq: PPDI) today announced that its board of directors declared a cash dividend for the third quarter of 2010 under its annual cash dividend policy. The quarterly cash dividend will equal $0.15 per share. The record date for the third quarter dividend is September 15, 2010, and the payme...
|
|
PPD Expands cGMP Laboratory Services in North America
Jul 29, 2010
|
11.2 KB |
|
| |
WILMINGTON, N.C (July 29, 2010) - PPD, Inc. (Nasdaq: PPDI) today announced it has expanded its cGMP laboratory testing services into Wayne, Pa., to meet growing client demand for these services from pharmaceutical and biotechnology companies located in the northeastern ...
|
|
PPD Reports Second Quarter 2010 Financial Results
Jul 27, 2010
|
101.1 KB |
|
| |
Highlights:
Gross authorizations of $610 million; net authorizations of $465 million
Development segment operating margin increased over 100 basis points sequentially
Cash flow from operations of $59 million
Completed spin-off of compound partnering business
...
|
|
PPD and Microsoft to Deliver Innovative REMS Solution Based on Microsoft Technologies
Jul 27, 2010
|
11.7 KB |
|
| |
WILMINGTON, N.C. (July 27, 2010) - PPD, Inc. (Nasdaq: PPDI) and Microsoft Corp. (Nasdaq: MSFT) today announced they have entered into an agreement to jointly implement an innovative technology solution designed to improve efficiency in managing U.S. Food and Drug Administration-mandated Risk Evaluation and Mitigation Strategy (REMS) progr...
|
|
PPD Names Henrietta Ukwu, M.D., Senior Vice President of Global Regulatory Affairs
Jul 14, 2010
|
10.4 KB |
|
| |
WILMINGTON, N.C. (July 14, 2010) - PPD, Inc. (Nasdaq: PPDI) announced it has appointed Henrietta Ukwu, M.D., FACP, FRAPS, as senior vice president of global regulatory affairs. She will have global responsibility for regulatory services across all PPD lines of business and provide clinical vaccine expertise to advance the company's vaccin...
|
|
PPD and Lovelace Biomedical and Environmental Research Institute Enter into Collaboration for Laboratory, Preclinical and Clinical Research Services
Jul 13, 2010
|
10.9 KB |
|
| |
WILMINGTON, N.C. (July 13, 2010) - PPD, Inc. (Nasdaq: PPDI) and Lovelace Biomedical and Environmental Research Institute (LBERI) today announced they have entered into a collaboration focused on future service opportunities for biopharmaceutical and government clients across a range of therapeutic areas.
Under the collaboration, ...
|
|
PPD Celebrates 25 Years with Ringing of Nasdaq Opening Bell
Jun 29, 2010
|
10.2 KB |
|
| |
WILMINGTON, N.C. (June 29, 2010) - PPD, Inc. (Nasdaq: PPDI) today announced it will ring the Nasdaq Stock Market Opening Bell on July 1 at 9:30 a.m. ET to commemorate PPD's history as one of the world's leading contract research organizations.
"For the past 25 year...
|
|
PPD to Sponsor Beach2Battleship Iron Distance Triathlon
Jun 28, 2010
|
10.3 KB |
|
| |
WILMINGTON, N.C. (June 28, 2010) - PPD, Inc. (Nasdaq: PPDI) announced today it will serve as title sponsor of the third annual Beach2Battleship Iron Distance Triathlon, an internationally recognized competition to be held in Wrightsville Beach and Wilmington, N.C., on November 13, 2010. The event has been renamed the ...
|
|
PPD Announces Second Quarter 2010 Earnings Release, Webcast and Conference Call
Jun 22, 2010
|
8.6 KB |
|
| |
WILMINGTON, N.C. (June 22, 2010) - PPD, Inc. (Nasdaq: PPDI) will release its second quarter 2010 financial results on Tuesday, July 27, 2010, after the market closes. The earnings release will be available on the PPD website at www.ppdi.com.
On Wednesday, July 28, 2010, at 9 a.m. ET, PPD will cond...
|
|
PPD Named Best Contract Research Organization in Asia at 2010 Vaccine Industry Excellence Awards
Jun 16, 2010
|
9.7 KB |
|
| |
WILMINGTON, N.C. (June 16, 2010) - PPD, Inc. (Nasdaq: PPDI) today announced it has been named Best Contract Research Organization (CRO) in Asia at the World Vaccine Congress' inaugural 2010 Vaccine Industry Excellence (ViE) Asia Awards held in Singapore on June 9. The award recognizes PPD's quality of services provided in Asia and its lon...
|
|
PPD Names Mike Wilkinson as Executive Vice President and Chief Information Officer, Paul Colvin as Executive Vice President of Global Clinical Development
Jun 15, 2010
|
10.4 KB |
|
| |
WILMINGTON, N.C. (June 15, 2010) - PPD, Inc. (Nasdaq: PPDI) today announced it has appointed Mike Wilkinson, Ph.D., as executive vice president and chief information officer and Paul Colvin as executive vice president of global clinical development effective June 30.
As executive vice president and chief information officer, Dr....
|
|
PPD and Furiex Announce Completion of Spin-off
Jun 15, 2010
|
11.1 KB |
|
| |
WILMINGTON, N.C., and MORRISVILLE, N.C. (June 15, 2010) - PPD, Inc. (Nasdaq: PPDI) and Furiex Pharmaceuticals, Inc. (Nasdaq: FURX) announced today the successful completion of the spin-off of Furiex. As previously announced, PPD received a private letter ruling from the Internal Revenue Service that the dividend of common stock of Furiex ...
|
|
PPD Rated One of Top CROs in Europe in 2010
Jun 11, 2010
|
9.4 KB |
|
| |
Company earns number two ranking in CenterWatch's European site survey
WILMINGTON, N.C. (June 11, 2010) - PPD, Inc. (Nasdaq: PPDI) today announced it has been rated one of Europe's top contract research organizations (CROs) in the 2010 CenterWatch European Site Survey. The company earned a number two ranking amo...
|
|
PPD Announces Effectiveness of Furiex Pharmaceuticals' Registration Statement on Form 10
May 27, 2010
|
10.3 KB |
|
| |
WILMINGTON, N.C. (May 27, 2010) - PPD, Inc. (Nasdaq: PPDI) announced today that, in connection with its proposed spin-off of Furiex Pharmaceuticals, Inc., the Securities and Exchange Commission has declared effective Furiex Pharmaceuticals' Registration Statement on Form 10.
Furiex Pharmaceuticals' common stock is expected to beg...
|
|
PPD Launches Expert Community for Online, Interactive Exchange of Industry Viewpoints
May 26, 2010
|
10.5 KB |
|
| |
WILMINGTON, N.C. (May 26, 2010) - PPD, Inc. (Nasdaq: PPDI) today announced it has launched Expert Community, an online, interactive area on its corporate website, www.ppdi.com, where company and other industry professionals can engage in a robust exchang...
|
|
PPD Sets Record and Distribution Dates for Spin-Off of Furiex Pharmaceuticals
May 24, 2010
|
11.0 KB |
|
| |
WILMINGTON, N.C. (May 24, 2010) - PPD, Inc. (Nasdaq: PPDI) announced today its board of directors has set the shareholder of record and distribution dates in connection with the spin-off of its wholly-owned subsidiary, Furiex Pharmaceuticals, Inc. Shareholders of record of PPD on June 1, 2010, will receive on June 14, 2010, a pro-rata div...
|
|
PPD Declares Second Quarter Dividend
May 20, 2010
|
8.6 KB |
|
| |
WILMINGTON, N.C. (May 20, 2010) - PPD, Inc. (Nasdaq: PPDI) today announced that its board of directors declared a cash dividend for the second quarter of 2010 under its annual cash dividend policy. The quarterly cash dividend will equal $0.15 per share. The record date for the second quarter dividend is June 15, 2010, and the payment date...
|
|
PPD Opens Pharmacovigilance and Medical Communications Center in Sofia, Bulgaria
May 5, 2010
|
11.3 KB |
|
| |
WILMINGTON, N.C. (May 5, 2010) - PPD, Inc. (Nasdaq: PPDI) today announced the opening of a pharmacovigilance and medical communications center in Sofia, Bulgaria, delivering its full range of drug safety, medical information and medical writ...
|
|
PPD's Contract Research Facility in Athlone, Ireland, Awarded Licenses by Irish Medicines Board
Apr 27, 2010
|
9.6 KB |
|
| |
WILMINGTON, N.C. (April 27, 2010) - PPD, Inc. (Nasdaq: PPDI) today announced its contract research facility in Athlone, Ireland, has been awarded manufacturer licenses by the Irish Medicines Board (IMB). The licenses support investigational medicinal products and marketed products and provide laboratory certifications for quality control ...
|
|
|
